minaprine has been researched along with ALS - Amyotrophic Lateral Sclerosis in 1 studies
minaprine: Agr 1240 refers to di-HCl; short-acting type A MAO inhibitor (MAOI) of mild potency; structure
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, T | 1 |
| Benmohamed, R | 1 |
| Kim, J | 1 |
| Smith, K | 1 |
| Amante, D | 1 |
| Morimoto, RI | 1 |
| Kirsch, DR | 1 |
| Ferrante, RJ | 1 |
| Silverman, RB | 1 |
1 other study available for minaprine and ALS - Amyotrophic Lateral Sclerosis
| Article | Year |
|---|---|
ADME-guided design and synthesis of aryloxanyl pyrazolone derivatives to block mutant superoxide dismutase 1 (SOD1) cytotoxicity and protein aggregation: potential application for the treatment of amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Animals; Blood-Brain Barrier; Caco-2 Cells; Cell Membrane Permeabilit | 2012 |